Medical Marijuana Effective For Reducing Migraine: Study Finds

People, who experience migraine, are turning toward medical marijuana as the drug of their choice to lower the pain they are enduring. Findings of a new study proven that this cannabis is helpful for all people who suffer chronic headaches.

Migraine affects 18 percent of women and 6 percent of men among the world's population as posted in MediCann. Though the primary cause of this condition remains unclear, it has been classified to be a chronic headache that lasts for several hours and for some, it even lasts for days. This condition is sometimes accompanied by vomiting, nausea and being very sensitive to environmental stimuli such as lights and sounds.

On the other hand, an improvement was noted among patients who were given medical marijuana starting January 2010 to September 2014. Patients felt better and were observed to have an increase ability to function during the treatment.

The said study involved 121 adult patients and 103 of them reported that their frequency of having migraines every month was down from 10.4 to 4.6 s reported in the Science World Report. The research scrutinized the charts of the patients at Gedde Whole Health, a private medical practice located in Colorado, which specializes in recommending the use of marijuana for different of conditions.

Furthermore, the study's author Professor Laura Borgelt PharmD, FCCP, BCPS, shared that marijuana has benefits as well as such potential risks like in any other drug. It is also important to know the proper use of medical marijuana and the adverse effects it may offer. The researcher also admitted that the exact mechanism of action of marijuana is still unknown and that they are still doing their best to find out how this cannabis helps migraine frequency to decrease.

Generally, medical marijuana is marking its stand in the pharmacological aspect of health. Borgelt believed that the findings of the research was remarkable enough but stressed that there is still a need for more controlled studies in the near future.